🇺🇸 FDA
Patent

US 7888389

Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies

granted A61KA61K31/205A61K31/28

Quick answer

US patent 7888389 (Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/205, A61K31/28, A61P, A61P27/02